title: Refractory antilaminin γ1 pemphigoid successfully treated with intravenous immunoglobulin and mycophenolate mofetil.
authors.affiliation: Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
authors.forename: A
authors.initials: A
authors.lastname: Alloo
authors.forename: L
authors.initials: L
authors.lastname: Strazzula
authors.forename: B
authors.initials: B
authors.lastname: Rothschild
authors.forename: E
authors.initials: E
authors.lastname: Hawryluk
authors.forename: D
authors.initials: D
authors.lastname: Levine
authors.forename: M P
authors.initials: MP
authors.lastname: Hoang
authors.forename: H
authors.initials: H
authors.lastname: Koga
authors.forename: T
authors.initials: T
authors.lastname: Hashimoto
authors.forename: D
authors.initials: D
authors.lastname: Kroshinsky
mesh_terms: D000369:Aged, 80 and over; D001323:Autoantibodies / Q000097:blood*; D001324:Autoantigens / Q000276:immunology; D004338:Drug Combinations; D005500:Follow-Up Studies; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007797:Laminin / Q000276:immunology*; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010391:Pemphigoid, Bullous / Q000188:drug therapy* / Q000276:immunology
chemical_list: D001323:Autoantibodies; D001324:Autoantigens; D004338:Drug Combinations; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D007797:Laminin; C089141:laminin gamma 1; D009173:Mycophenolic Acid